Mavacamten, also known as SAR-439152 and MYK-461, is the first (first-in-class) oral bioavailability of an allosteric and reversible selective inhibitor of cardiac myosin. It can regulate the sarcomere contraction of hypertrophic cardiomyopathy, and the
Molecular Weight:
273.33
Purity:
99.80%
CAS Number:
[1642288-47-8]
Formula:
C15H19N3O2
Target:
Myosin
* VAT and and shipping costs not included. Errors and price changes excepted